Rafael Holdings, Inc. (RFL): Cash & Equivalents
$52.77M
As of 2025-07-31
$30.50M
As of 2026-04-30
+25.8%
3-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-07-31 | $52.77M | n/m | 2025-10-29, Balance as of period end |
| 2024-07-31 | $2.67M | -87.6% | 2025-10-29, Balance as of period end |
| 2023-07-31 | $21.50M | -19.0% | 2024-12-20, Balance as of period end |
| 2022-07-31 | $26.54M | +237.9% | 2023-10-30, Balance as of period end |
| 2021-07-31 | $7.85M | n/c | 2022-10-31, Balance as of period end |
| 2020-07-31 | $6.21M | -48.4% | 2021-10-18, Balance as of period end |
| 2019-07-31 | $12.02M | -23.9% | 2020-10-29, Balance as of period end |
| 2018-07-31 | $15.80M | +34.4% | 2019-10-04, Balance as of period end |
| 2017-07-31 | $11.76M | +402.6% | 2018-10-15, Balance as of period end |
| 2016-07-31 | $2.34M | n/a | 2018-10-15, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Rafael Holdings, Inc. (RFL) | 2025-07-31 | $52.77M | n/m |
| Rallybio Corp (RLYB) | 2025-12-31 | $31.37M | +125.7% |
| Shattuck Labs, Inc. (STTK) | 2025-12-31 | $54.19M | -5.6% |
| 60 Degrees Pharmaceuticals, Inc. (SXTP) | 2025-12-31 | $1.51M | -9.0% |
| Dare Bioscience, Inc. (DARE) | 2025-12-31 | $24.71M | +57.4% |
| China SXT Pharmaceuticals, Inc. (SXTC) | 2026-03-31 | $28.18M | +55.7% |
| Neuphoria Therapeutics Inc. (NEUP) | 2026-06-30 | $19.87M | +39.8% |
| Longeveron Inc. (LGVN) | 2025-12-31 | $4.66M | -75.8% |
| Vistagen Therapeutics, Inc. (VTGN) | 2026-03-31 | $30.79M | -54.1% |
Compare RFL, RLYB, STTK, SXTP side by side · Screen every company in Pharmaceutical Preparations ↗